Altre lingue Glenmark Pharmaceuticals Limited

Azioni

GLENMARK

INE935A01035

Tempo differito NSE India S.E. Altri mercati azionari 12:10:12 24/04/2024			Variaz. 5gg	Var. 1 gen.
1.071 ^INR	+3,52%		+2,80%	+25,41%

01/04	Glenmark Pharmaceuticals Limited annuncia cambiamenti nel Consiglio d'Amministrazione	CI
12/03	Nirma Limited ha completato l'acquisizione del 75% di Glenmark Life Sciences Limited (NSEI:GLS) da Glenmark Pharmaceuticals Limited (NSEI:GLENMARK) (GPL).	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Glenmark Pharmaceuticals Limited Announces Board Changes	01/04
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
Indian shares set to open higher	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Glenmark Pharma, Pfizer Launch Atopic Dermatitis Oral Treatment in India	01/02
Indian shares set to open higher ahead of national budget	01/02
Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance 'Ichnos Glenmark Innovation'	31/01
Glenmark Pharmaceuticals Limited Partners with Pfizer to Launch Abrocitinib in India	31/01
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 for Multiple Geographies around the World	26/01
Alphamab Oncology Unit, 3D Medicines Grants Glenmark Unit License to Commercialize Sarcoma Injectable	25/01
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Pharmaceuticals Limited Launches Biosimilar of the Popular Antidiabetic Drug, Liraglutide, for the First Time in India	03/01
Glenmark Pharmaceuticals Introduces Anti-Diabetic Drug Liraglutide in India	03/01
Glenmark Pharmaceuticals : is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India	03/01
Glenmark Pharmaceuticals Swings to Loss in Fiscal Q2; Shares Slide 5%	14/11
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Anti-Psychotic Drug	07/11
Glenmark Pharmaceuticals Limited Receives ANDA Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg	07/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Glenmark Pharmaceuticals Limited

Azioni

GLENMARK

INE935A01035

Altre lingue

Filtri